Patents
Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
Published in Biotech Law Weekly, August 31st, 2007
The claims cover a broad class of novel TLR9 agonists containing short DNA sequences separated by spacer molecules. These linear chimeric immunomodulatory compounds (CICs), are being developed at Dynavax for application across a wide range of therapeutic categories. The claims cover CICs with or without antigen, and alone or in a pharmaceutical preparation. The current term for this patent expires in June 2022. The patent, U.S. patent No. 7,255,868 B2, was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2007-08-31)
More Articles from Biotech Law Weekly
- Acara Partners
Acara Expands to Nationwide Search for Its Medical Spa Acquisition Strategy - ADA Watch Coalition and National Coalition for Disability Rights
Senator Tom Harkin Calls for Restoration of Americans with Disabilities Act on the 'Road to Freedom' National Bus Tour - Addiction Medicine
Online Tool Educates MySpace Generation about Opioid Addiction - Amvets
AMVETS to Step Up Recruitment of Younger Veterans as it Fights for Mandatory Funding of Veterans Healthcare - Autism
Deirdre Imus, Katie Wright to Speak at '07 National Autism Conference, Atlanta - Bally Total Fitness
Bally Total Fitness Announces Noteholder Support for Proposed Amendments to Plan of Reorganization Sponsored by Harbinger Capital Partners Funds - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
